RFS
BIO icon

Rockefeller Financial Services’s Bio-Rad Laboratories Class A BIO Stock Holding History

Rockefeller Financial Services’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-81
Closed -$11K – 488
2016
Q1 		$11K Buy
+81
New +$10.6K ﹤0.01% 520

Other funds holding BIO

ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

Rockefeller Financial Services's BIO Position: Q2 2016 in Review

Rockefeller Financial Services sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2016, closing a stake of 81 shares — an estimated $11K sold.

Rockefeller Financial Services first reported a position in BIO in Q1 2016 and held it in 1 quarter. The position peaked at $11K in Q1 2016. 236 funds tracked by Wall St. Rank hold BIO as of Q2 2016.

  • Rockefeller Financial Services reported no remaining Bio-Rad Laboratories Class A position as of Q2 2016 after selling out during the quarter.
  • Rockefeller Financial Services sold 81 Bio-Rad Laboratories Class A shares in Q2 2016, an estimated $11K.
  • Rockefeller Financial Services first reported a position in Bio-Rad Laboratories Class A in Q1 2016 and held it in 1 quarter.
  • Rockefeller Financial Services's Bio-Rad Laboratories Class A position peaked at $11K in Q1 2016.
  • 236 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2016.

Based on Rockefeller Financial Services's 13F filing for Q2 2016, filed 20 Jul 2016.